A homozygous PRDX3 pathogenic variant in a paediatric case of spinocerebellar ataxia type 32

Spinocerebellar ataxia type 32 (SCAR32) is a rare autosomal neurodegenerative disorder caused by mutations in the peroxiredoxin 3 (PRDX3) gene, which encodes a mitochondria-specific antioxidant enzyme critical for maintaining cellular redox homeostasis. Here, we reported a case of a homozygous nonsense mutation (c.619 C > T; p.Arg207*) in PRDX3 of a 12-year-old Chinese boy. This mutation was predicted to result in premature termination of protein translation. Consequently, the patient presented with slowly progressive gait ataxia and cerebellar vermis atrophy. Mild cognitive impairment was also observed, with deficits in perceptual reasoning and processing speed. Additionally, he showed increased thyroid autoantibodies and thyroid enlargement. This case broadens the phenotypic spectrum of PRDX3-related disease, highlights its genetic and clinical heterogeneity, and reinforces the importance of early genetic testing in paediatric ataxia.

Authors

Institutions

Publication Details

Journal
Neurogenetics
Published
2025-12-06
DOI
https://doi.org/10.1007/s10048-025-00869-w
Primary Topic
Redox biology and oxidative stress
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A homozygous PRDX3 pathogenic variant in a paediatric case of spinocerebellar ataxia type 32

Hongfang Jiang, Jiaxuan Yang, Yue-Ping Che, Haifeng Li et al.
Neurogenetics
Redox biology and oxidative stress
article

A homozygous PRDX3 pathogenic variant in a paediatric case of spinocerebellar ataxia type 32

Hongfang Jiang, Jiaxuan Yang, Yue-Ping Che, Haifeng Li, Daqing Ma, Yonglin Yu, Yaoqin Hu, Dingwen Wu, Jinpiao Zhu
article en

Abstract

Spinocerebellar ataxia type 32 (SCAR32) is a rare autosomal neurodegenerative disorder caused by mutations in the peroxiredoxin 3 (PRDX3) gene, which encodes a mitochondria-specific antioxidant enzyme critical for maintaining cellular redox homeostasis. Here, we reported a case of a homozygous nonsense mutation (c.619 C > T; p.Arg207*) in PRDX3 of a 12-year-old Chinese boy. This mutation was predicted to result in premature termination of protein translation. Consequently, the patient presented with slowly progressive gait ataxia and cerebellar vermis atrophy. Mild cognitive impairment was also observed, with deficits in perceptual reasoning and processing speed. Additionally, he showed increased thyroid autoantibodies and thyroid enlargement. This case broadens the phenotypic spectrum of PRDX3-related disease, highlights its genetic and clinical heterogeneity, and reinforces the importance of early genetic testing in paediatric ataxia.

NeurogeneticsVol. 26(1)
Children's Hospital of Zhejiang University (CN), Chelsea and Westminster Hospital (GB)
National Natural Science Foundation of China, Zhejiang University
Openalex Percentile: Top 65%
Redox biology and oxidative stress
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A homozygous PRDX3 pathogenic variant in a paediatric case of spinocerebellar ataxia type 32 — Hongfang Jiang, Jiaxuan Yang, et al. · Neurogenetics (2025) | TGRS Research Map | TGRS